Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of Enasidenib in People With T-Cell Lymphoma

Phase 2

Recruiting

Conditions: T-cell Lymphoma

Interventions: Drug: Enasidenib
Drug: Rituximab

First Posted Date: 2025-01-02

Last Posted Date: 2025-01-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT06756308

Locations: 🇺🇸
Dana Farber Cancer Institute (Data Collection Only), Boston, Massachusetts, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (Limited Protocol Activities), Basking Ridge, New Jersey, United States

and more 5 locations

A Study of a Weight Loss Intervention in People With Endometrial Cancer

Early Phase 1

Recruiting

Conditions: Endometrial Cancer

Interventions: Drug: Tirzepatide

First Posted Date: 2024-12-30

Last Posted Date: 2025-01-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 36

Registration Number: NCT06751589

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 4 locations

A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

Phase 2

Recruiting

Conditions: Non Small Cell Lung Cancer Metastatic

Interventions: Drug: osimertinib
Radiation: stereotactic radiosurgery (SRS)

First Posted Date: 2024-12-18

Last Posted Date: 2025-05-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 56

Registration Number: NCT06741085

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Phase 2

Recruiting

Conditions: Diffuse Large B Cell Lymphoma
High-grade B-cell Lymphoma
Stage III High Grade B-Cell Lymphoma
Stage IV High Grade B-Cell Lymphoma
DLBCL - Diffuse Large B Cell Lymphoma
Intravascular Large B-Cell Lymphoma
Diffuse Large B Cell Lymphoma of Breast
Diffuse Large B Cell Lymphoma of Testis
HIV-associated Diffuse Large B Cell Lymphoma
Double Expressor DLBCL

First Posted Date: 2024-12-17

Last Posted Date: 2025-05-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT06736613

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors

Phase 2

Recruiting

Conditions: Breast Cancer Survivor

First Posted Date: 2024-12-11

Last Posted Date: 2025-05-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 200

Registration Number: NCT06728579

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

and more 6 locations

A Study of Language Interpretation Solutions for People With Breast Cancer

Not Applicable

Recruiting

Conditions: Breast Cancer
Breast Cancer Stage II
Breast Cancer Stage III

First Posted Date: 2024-12-06

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 640

Registration Number: NCT06721065

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent Only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent Only), Montvale, New Jersey, United States

and more 5 locations

A Study of Lung Cancer Screening in People With Unexplained Weight Loss

Recruiting

Conditions: Lung Cancer Screening

First Posted Date: 2024-12-05

Last Posted Date: 2025-05-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 409

Registration Number: NCT06717334

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

and more 5 locations

A Study of Surgical Techniques During Cystectomy

Phase 3

Recruiting

Conditions: Bladder Cancer

Interventions: Procedure: Stent placement
Drug: Alvimopan

First Posted Date: 2024-11-25

Last Posted Date: 2025-04-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 530

Registration Number: NCT06703476

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Consent Only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent Only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent Only), Montvale, New Jersey, United States

and more 4 locations

A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Phase 2

Recruiting

Conditions: Renal Cell Carcinoma

Interventions: Drug: Cemiplimab
Drug: Fianlimab

First Posted Date: 2024-11-21

Last Posted Date: 2025-04-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT06699602

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activites), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Phase 2

Recruiting

Conditions: T-Cell Leukemia/Lymphoma, Adult
T-cell Leukemia/Lymphoma
T-cell Leukemia
Lymphoma

Interventions: Drug: Mogamulizumab

First Posted Date: 2024-11-20

Last Posted Date: 2025-03-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 134

Registration Number: NCT06698003

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy